Michael Burry Likes Lululemon Stock. But the Math Only Works If Sales Stop Shrinking.

Lululemon shares closed at a fresh 52-week low of $96.88 after falling 17% following its second full-year guidance cut, with FY EPS now expected at $9.48-$9.73 versus $13.26 last year, implying a roughly 28% decline at the midpoint. Fiscal Q2 comparable sales fell 9%, including a 12% decline in the Americas, while Q3 revenue is projected to drop 10%-11%; reported Q2 EPS of $2.92 included a $0.86 boost from tariff refunds and interest. Michael Burry has made Lululemon his largest position, citing its approximately $1.4B cash balance, zero debt, aggressive buybacks and roughly 10x guided EPS valuation, but the investment case depends on stabilizing declining sales.

Analysis

The relevant valuation is not the headline earnings multiple but a normalized, post-promotion, post-tariff-benefit earnings base. If revenue deleveraging forces incremental markdowns, store labor deleverage, and higher customer-acquisition spend, the earnings trough can move materially below current guidance; buybacks then offset share count but do not cure declining unit economics. The key read-through is gross-margin trajectory and inventory turns in the next report, not whether management merely meets a reduced EPS target.

A new CEO creates a credible 6-18 month operational catalyst, but also raises near-term execution risk: a brand reset can require assortment rationalization, marketing investment, and promotional clearance before demand stabilizes. NKE is a partial beneficiary if premium activewear consumers migrate toward established performance brands, though its own turnaround makes it an imperfect clean hedge; ONON and DECK are more likely relative-share beneficiaries if consumers are rotating rather than abandoning premium athletic spend.

Consensus may be too focused on the apparent floor created by capital returns. Repurchases below intrinsic value are accretive only if the business retains enough pricing power to stabilize free cash flow; persistent negative comps can turn the authorization into a signal of limited internal reinvestment opportunities. Conversely, the stock can re-rate sharply before reported growth returns if Americas traffic, full-price sell-through, and gross margin sequentially improve, because expectations are now anchored to continued deterioration.

Key Decisions for Investors

• Do not initiate a directional LULU long solely on the low multiple. Establish a watch trigger for a sequential improvement in Americas comparable sales and stable-to-up gross margin at the next earnings report; a position after that confirmation offers better 6-12 month risk/reward than attempting to call the trough now.
• For a tactical bearish expression into the next earnings update, use a defined-risk LULU put spread dated 1-2 months beyond the report rather than outright short stock. The thesis is further guidance compression from promotional and margin pressure; exit if management shows sequential traffic improvement and maintains gross margin despite lower sales.
• Consider a small relative-value basket: long ONON and/or DECK versus short LULU over the next 3-6 months, sized modestly because consumer-discretionary beta and broad retail demand are shared risks. The trade is invalidated if LULU demonstrates stabilized full-price sell-through while peers begin reporting slowing North American growth.
• Treat any sharp LULU rebound driven by investor-following or buyback headlines as an opportunity to reassess rather than chase. The fundamental falsifier for the bearish/neutral stance is two consecutive quarters of improving comparable-sales trends coupled with evidence that inventory and markdown rates are normalizing.